This site is intended for Healthcare Professionals only

MHRA

tablets-1280

MHRA suspends use, supply and sale of Avacopan Vifor to new patients

The medicines regulator said the study underpinning the drug's authorisation can no longer be relied on to demonstrate its efficacy.

02 Sep 2026

hayfever-1280x720

Fluticasone 0.05pc nasal spray reclassified to be available for children aged 12 and over

MHRA reclassifies fluticasone nasal spray as a P medicine for those aged 12 years and over, available from February 2026.

16 Dec 2025

main pic spread copy.jpg

Key clinical developments in 2021

This module provides an update of the major developments in pharmacy practice during 2021.

16 Dec 2021

Change privacy settings